Evaluating the effectiveness of botulinum toxin using a human neuromuscular junction model
Official title: Human NeuromuscularJunction Platform to Evaluate Botulinum Toxin Potency
Funded at Hesperos, LLC · NIH-11078349 · Data updated 2026-11-12
This study is working on a kinder and more efficient way to test how strong Botox is by using a human model instead of relying on animal testing, which could help make Botox safer and more effective for everyone who uses it.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Hesperos, LLC NIH-funded |
| Lab location | 1 site (Orlando, United States) |
| Project start | April 24, 2024 |
| Project end | March 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $1,000,000 |
| NIH project number | 5U44TR004811-02 |
| Project ID | NIH-11078349 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who require Botox treatments for conditions such as vocal muscle spasticity, strabismus, hyperactive urinary bladder, excessive sweating, or chronic migraines.
✕Less likely to help
Patients who do not require Botox treatments or those with conditions unrelated to the effects of botulinum toxin may not benefit from this research.
What this research studies
This research focuses on developing a new method to assess the potency of botulinum toxin (commonly known as Botox) using a human neuromuscular junction model. Currently, the potency is measured through a mouse lethality bioassay, which involves sacrificing over a million animals each year. The new approach aims to create a more ethical and efficient testing method that could potentially replace animal testing. By validating this method with the FDA, the research seeks to ensure that Botox can be tested safely and effectively for various medical and cosmetic applications.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and humane testing methods for Botox, ultimately improving treatment options for patients.
How similar studies have gone: Previous research has shown promise in using human cell models for drug testing, indicating that this approach could be a significant advancement in the field.
Where this research is happening
-
Hesperos, LLC
Orlando, United States Active
Researchers
- Principal investigator: Kronauge, James F — Hesperos, LLC
- Study coordinator: Kronauge, James F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.